Page last updated: 2024-10-26

felodipine and Epilepsy

felodipine has been researched along with Epilepsy in 1 studies

Felodipine: A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.
felodipine : The mixed (methyl, ethyl) diester of 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium-channel blocker, it lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. It is used in the management of hypertension and angina pectoris.

Epilepsy: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)

Research Excerpts

ExcerptRelevanceReference
"Felodipine is a dihydropyridine calcium antagonist, structurally related to nifedipine, which undergoes extensive first-pass hepatic metabolism and normally has an oral bioavailability of 15%."1.27Reduced felodipine bioavailability in patients taking anticonvulsants. ( Capewell, S; Critchley, JA; Freestone, S; Pottage, A; Prescott, LF, 1988)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Capewell, S1
Freestone, S1
Critchley, JA1
Pottage, A1
Prescott, LF1

Other Studies

1 other study available for felodipine and Epilepsy

ArticleYear
Reduced felodipine bioavailability in patients taking anticonvulsants.
    Lancet (London, England), 1988, Aug-27, Volume: 2, Issue:8609

    Topics: Administration, Oral; Adult; Anticonvulsants; Antipyrine; Biological Availability; Drug Administrati

1988